Bill tracker, H.Res. 1285, Health
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
- Introduced
- In committee
- Reported
- Agreed to in the House
Introduced May 14, 2026 with 54 cosponsors. Latest action May 14, 2026: Referred to the House Committee on Energy and Commerce.
Sponsor
Committees
- Energy and Commerce Committee
Referred To May 14, 2026
Timeline
What happened to it
- No major action since May 14, 2026 (6 months)Last step: Introduced
Related bills
Full history
- ReferredHouse. Referred to the House Committee on Energy and Commerce.
- IntroducedSubmitted in House
